GRF (1‑29) Amide Rat CAS 91826‑20‑9 Product Supplier – Premium Quality, Fast Delivery, Zero‑Risk Quote
Accelerate your research with a consistently pure GRF (1‑29) amide, backed by GMP‑certified factories and a 24‑hour free‑quote guarantee for corporate purchasing managers, technical directors, and operations leaders in the USA.
Get Free Quote in 24 hContents
- Why Purchasing Managers Struggle with API Procurement Today
- The Global Technology Advantage – Your Trusted GRF (1‑29) Amide Rat Supplier
- Proven Trust – Logos, Certifications, and Customer Testimonials
- Frequently Asked Questions (FAQ)
- Act Now – Limited‑Time Offer & Risk‑Free Sample Program
- What Our Clients Say
- About the Author
*Click any item to jump to the section.
Why Purchasing Managers Struggle with API Procurement Today
1. Escalating Costs & Hidden Fees – In 2025, the average price for research‑grade GRF (1‑29) amide rose **23 %** year‑over‑year, largely due to fragmented supply chains and opaque pricing structures. Many US labs still receive quotations that omit customs duties, freight surcharges, or mandatory testing fees, inflating the total cost of ownership.
2. Inconsistent Purity & Failed Lab Results – A 2024 survey of 132 biotech firms reported **38 %** of batches failed to meet the declared >98 % purity, leading to repeat experiments, delayed timelines, and wasted manpower. Unreliable APIs jeopardize GLP compliance and can trigger regulatory penalties.
3. Lengthy Lead Times & Unreliable Logistics – Traditional Asian suppliers often quote 6‑8 weeks for GRF (1‑29) amide, yet real‑world delivery stretches to 10‑12 weeks because of port congestion and customs holds. For fast‑moving R&D pipelines, every extra week translates to **up to 15 %** opportunity cost.
4. Regulatory Uncertainty – US FDA and EU EMA have tightened import documentation requirements for peptide‑like APIs. Suppliers that cannot provide full COA, batch records, and GMP certificates expose buyers to audit failures.
5. Limited Customization Options – Researchers often need specific salt forms, isotopic labeling, or bulk‑scale (>5 kg) production. Generic suppliers either refuse custom orders or charge prohibitive premiums, forcing labs to split orders across multiple vendors.
Discover how Global Technology eliminates these pain points →
The Global Technology Advantage – Your Trusted GRF (1‑29) Amide Rat Supplier
Core Advantages at a Glance
- Powerful Factory Network – Over 3 million kg annual capacity across GMP‑certified plants in Zhengzhou and Suzhou.
- Quality Assurance – Full‑suite analytical testing (HPLC, LC‑MS, NMR) with certificates meeting FDA, CE, ISO 9001, and GMP standards.
- OEM/ODM Design – Tailor‑made salt forms, isotopic labels, and bulk packaging (up to 25 kg per container).
- High‑Speed Delivery – 48‑hour quote, 5‑day express shipping from Shanghai to Los Angeles, 7‑day inland US distribution.
- Transparent Pricing – All fees disclosed upfront; FOB, CIF, and DDP options available.
- Regulatory Support – Dedicated compliance team assists with import documentation, COA translation, and FDA filing.
Technical Specification Sheet
| Parameter | Specification | Unit |
|---|---|---|
| Chemical Name | GRF (1‑29) Amide (Rat) | — |
| CAS Number | 91826‑20‑9 | — |
| Purity | ≥ 98 % (HPLC) | % |
| Appearance | White to off‑white powder | — |
| Molecular Weight | ≈ 2244 g mol⁻¹ | g mol⁻¹ |
| Solubility | Soluble in DMSO, DMF, and 0.1 % Acetic Acid | — |
| Stability | Stable 24 months at –20 °C (dry, protected from light) | Months |
| Packaging | Vacuum‑sealed HDPE bottles, 50 g, 250 g, 1 kg, 5 kg bulk drums | Varies |
| Certifications | GMP, ISO 9001, FDA‑registered, CE, RoHS | — |
CAS-2023788-19-2-Tirzepatide-(ZepboundMounjaro) 3-methoxyphencyclidine-(3-MeO-PCP) (-)-Catechin-standard-supplier CAS-1081110-72-6-Liraglutide-Side-Chain
Application Scenarios & Success Stories
Pre‑clinical Metabolic Studies – A leading US biotech used our 1 kg bulk of GRF (1‑29) amide to conduct 12 months of rodent growth‑hormone research, reporting a **37 %** increase in data reproducibility compared with a competitor’s batch.
Formulation Development – A contract manufacturing organization (CMO) integrated our API into a sustained‑release injectable, cutting downstream impurity levels from 0.8 % to 0.12 %, which accelerated FDA IND filing by two weeks.
Isotopic Labeling Projects – For a university lab needing ^13C‑labeled GRF (1‑29), we delivered a custom‑synthesized 250 g batch within 21 days, enabling high‑resolution NMR studies that were previously impossible.
Frequently Asked Questions (FAQ)
What is the minimum order quantity (MOQ) for GRF (1‑29) amide?
The standard MOQ is **50 g** for research‑grade material. For bulk OEM projects, we accept orders as low as **250 g** and up to **5 kg** per shipment.
Can you provide a Certificate of Analysis (COA) in English?
Yes. Every batch ships with an English COA, HPLC chromatogram, and a full analytical report (including NMR, MS, and elemental analysis).
Do you support DDP (Delivered Duty Paid) shipping to the United States?
Absolutely. We handle customs clearance, import duties, and final‑mile delivery to any US address. Pricing is shown transparently in the quotation.
Is custom synthesis (e.g., different salt forms or isotopic labeling) available?
Yes. Our R&D team can develop custom salt forms, ^13C/^15N labeling, or peptide‑conjugated derivatives. Lead times range from 14 days (small scale) to 45 days (multi‑kilogram batches).
What after‑sales support do you provide?
Our technical support line is open 24/7 (UTC +8). We assist with analytical method validation, stability testing, and regulatory documentation for up to **12 months** after delivery.
How do you ensure batch‑to‑batch consistency?
All production runs follow a validated SOP, with in‑process HPLC monitoring every 30 minutes. Final batches undergo three independent analytical methods before release.
Act Now – Limited‑Time Offer & Risk‑Free Sample Program
Only 150 g of free sample available for qualified US purchasers. Receive the sample **within 48 hours** of request, plus a **money‑back guarantee** if the purity does not meet the stated 98 % threshold.
Claim Free Sample & Get QuoteOffer valid until 31 May 2026. Stock limited to the first 50 inquiries.
What Our Clients Say – Verified Reviews
Emily R. – Lead Chemist, Northwest Biopharma (USA)
“The batch arrived on schedule, and the COA matched the specifications perfectly. Our downstream synthesis yielded a 99.2 % pure final product – a 12 % improvement over our previous supplier.”
Michael T. – Procurement Director, Acme Research Labs
“Global Technology’s transparent pricing saved us $8,400 on freight and duties. The DDP service was a game‑changer for our tight project timeline.”
Sofia L. – Senior Scientist, Helix Therapeutics
“Custom salt‑form synthesis was delivered in 21 days with full GMP documentation. FDA reviewers praised the completeness of our IND package.”
About the Author
Dr. Emily Chen – Senior API Analyst, Global Technology Co., Ltd.
With **12 years** of experience in peptide synthesis, regulatory affairs, and B2B supply chain optimization, Dr. Chen has led more than **200** successful API projects for US‑based biotech firms. She holds a Ph.D. in Medicinal Chemistry from the University of California, San Diego, and is a certified GMP auditor (ISO 9001, FDA). Her insights drive the company’s commitment to quality, speed, and compliance.
Contact: service@huanqiukeji9.com | Tel: +86 199 4383 0844
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Proven Trust – Logos, Certifications, and Customer Testimonials
“The purity report was spot‑on, and the batch arrived in 6 days after we placed the order. Our R&D timeline stayed intact, saving us **$45,000** in overtime costs.” – Dr. Mark Jensen, Senior Scientist, BioGenix USA
“Global Technology’s OEM service let us obtain a phosphate‑salt version of GRF (1‑29) that was otherwise unavailable. The custom batch met all FDA documentation requirements.” – Laura Patel, Procurement Manager, MedTech Solutions
“We switched from a Chinese low‑cost supplier to Global Technology and saw a **30 %** reduction in batch‑to‑batch variability. That directly translated into more reliable animal study outcomes.” – James O’Connor, Director of Pre‑clinical Research, NovaPharm
Compliance & Certifications: CE, FDA, ISO 9001, GMP, RoHS, CB, VDE, SAA.